Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study

Anant Mahaveer Khot, H. V. Anuradha, V. S. Prakash, M. C. Shivamurathy

Open source

DOI
10.4103/jpp.jpp_168_16
Published
2017-03
Container
Journal of Pharmacology and Pharmacotherapeutics
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/jpp.jpp_168_16,
  title = {Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study},
  author = {Anant Mahaveer Khot and H. V. Anuradha and V. S. Prakash and M. C. Shivamurathy},
  year = {2017},
  journal = {Journal of Pharmacology and Pharmacotherapeutics},
  doi = {10.4103/jpp.jpp_168_16},
  url = {https://doi.org/10.4103/jpp.jpp_168_16}
}

RIS

TY  - JOUR
TI  - Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study
AU  - Anant Mahaveer Khot
AU  - H. V. Anuradha
AU  - V. S. Prakash
AU  - M. C. Shivamurathy
PY  - 2017
JO  - Journal of Pharmacology and Pharmacotherapeutics
DO  - 10.4103/jpp.jpp_168_16
UR  - https://doi.org/10.4103/jpp.jpp_168_16
ER  - 

APA

Khot, A. M., Anuradha, H. V., Prakash, V. S., & Shivamurathy, M. C. (2017). Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study. Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.4103/jpp.jpp_168_16

Source records